- Home
- LOPE vs RLAY Comparison
LOPE vs RLAY Comparison
Compare LOPE & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOPE | RLAY |
|---|---|---|
| Founded | 1949 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LOPE | RLAY |
|---|---|---|
| Price | $151.30 | $19.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $220.00 | $19.50 |
| AVG Volume (30 Days) | 264.7K | ★ 2.2M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 4.57 | N/A |
| Revenue | ★ $511,257,000.00 | $15,355,000.00 |
| Revenue This Year | $8.67 | N/A |
| Revenue Next Year | $6.66 | $324.03 |
| P/E Ratio | $33.16 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $134.27 | $3.89 |
| 52 Week High | $223.04 | $21.27 |
Technical Indicators
Market Signals| Indicator | LOPE | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 48.18 |
| Support Level | $149.60 | $18.00 |
| Resistance Level | $155.34 | $20.82 |
| Average True Range (ATR) | 3.71 | 0.79 |
| MACD | 0.34 | -0.11 |
| Stochastic Oscillator | 80.91 | 38.93 |
Price Performance
Historical ComparisonAbout LOPE Grand Canyon Education Inc.
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.